advanced search
John Merhige
Chief Commercial Officer
Credence MedSystems

Is this your profile?

About

John A. Merhige is Chief Commercial Officer at Credence MedSystems. Previously, he was Vice-President, Market Development at Sanofi BioSurgery. He came to Sanofi upon its acquisition of Pluromed in 2012, which John joined in its early stages and where he was a member of the executive management team. He led the commercial activities at Pluromed, which developed and commercialised rapid transition polymers for cardiovascular and other surgical procedures. Prior to Pluromed, John founded Prelude Devices to target early-stage medical device technologies for development and commercialisation. John is a member of PDA, MassMEDIC, MassBio and has served on the board of directors of the MedDev Group

Contributions

INTERVIEW
INTERVIEW: DOUG BRYANS, BRYLLAN & JOHN MERHIGE, CREDENCE
Douglas Bryans and John Merhige discuss the changing needs of drug developers around novel dual-chamber and ready-to-use drug delivery devices, capacity and the delivery of complete solutions from CDMOs and device developers, anchored around the recently announced partnership between Credence MedSystems and Bryllan to provide these critical services.

More contributions

PREFILLED SYRINGES
TAKING INTEGRATED NEEDLE SAFETY SYSTEMS FOR PREFILLED SYRINGES TO THE NEXT LEVEL
Michelle Deutsch and John Merhige discuss the needle safety requirements of prefilled syringes and consider how SCHOTT TOPPAC® and syriQ® PFS with Credence Companion® technology combine to meet these challenges, while ensuring the device meets sustainability demands.
CONNECTIVITY
THE AWARD-WINNING CREDENCE CONNECT™ AUTO-SENSING INJECTION SYSTEM
John Merhige explains how connectivity that is universally applicable to any existing prefilled syringe platform adds value throughout the ecosystem, both including and beyond the “compliance business model”.
VIDEO
VIDEO: Credence Connect from Credence MedSystems
Credence MedSystems takes us through the use steps of its new Credence Connect™ autosensing injection system, and smartphone app.
#97_May_2019_Credence_featured
INJECTION
TECHNOLOGY SHOWCASE: Credence MedSystems Multi-Site™ Injection System
Credence MedSystems introduces the Multi-Site™ Injection System – a product that addresses specific needs in the high-growth dermal filler market.
Phillips Med, feature image
INJECTION
A RE-USABLE CONNECTED AUTOINJECTOR CUSTOMISED FOR THE COMPANION® SAFETY SYRINGE SYSTEM
Bjarne Sørensen and John A. Merhige explore the latest developments in modular autoinjector platforms and the benefits for end users and pharmaceutical customers. They also discuss the two companies’ recent partnership for the development of a combined system that capitalises on important synergies between two compatible technologies.
INTERVIEW
JOHN A MERHIGE, CREDENCE MEDSYSTEMS
John Merhige discusses Credence’s Companion Safety Syringe System, new advances in the product development pipeline, customer/market driven feedback from user studies and exciting developments planned for 2018 that will take the company on to the next major phase in its growth.
PREFILLED SYRINGES
COMPANY SHOWCASE: CREDENCE MEDSYSTEMS
John Merhige overviews the offerings of Credence Medsystems, the Companion Product Family, and the company's Innovation Without Change philosophy.
INTERVIEW
JOHN A. MERHIGE, CREDENCE MEDSYSTEMS
John Merhige speaks about Credence’s history, people and devices, and what the company’s core philosophy, “Innovation Without Change” is really about, and how much it genuinely means to Credence.
PREFILLED SYRINGES
CREDENCE MEDSYSTEMS & THE CREDENCE COMPANION SAFETY SYRINGE SYSTEM
John A Merhige summarises the Credence Companion Safety Syringe System, and how it fits with the company’s core philosophy of Innovation Without Change for the benefit of biopharmaceutical partners.
PREFILLED SYRINGES
CREDENCE MEDSYSTEMS, INC & THE CREDENCE COMPANION SAFETY SYRINGE SYSTEM
Featuring for the first time in ONdrugDelivery Magazine, John A. Merhige introduces the Credence Companion Safety Syringes System. This innovative, modular technology provides fully customisable needle safety without coming into contact with the drug prior to use and without any change to the existing primary drug container.
Top